Virtual Event | April 30, 2024

Unlocking The Future Of Allogeneic Cell Therapy For Oncology

Source: Cell & Gene

Cell & Gene Live Chief Editor, Erin Harris, welcomed Cokey Nguyen, Chief Scientific and Technical Officer at Atara Bio and Loren Wagner, COO at Poseida Therapeutics.

During the digital event, panelists shared insights into potential trends driving the future of allogeneic therapies for oncology. They broke down the latest in allogeneic cell therapy research as well as major topics including immunogenicity and the manufacturing strategies needed to deliver clinically successful and long-lasting off-the-shelf treatments to patients in oncology.

access the Virtual Event!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests: